Drug discovery, the art of identifying new molecules to develop pharmaceuticals, is a notoriously time-consuming and difficult process. Traditional techniques, like high-throughput screening, offer an ...
The investments put the combined company at a valuation of $7.5 billion Playlist CEO Fritz Lanman and Egym co-founder and CEO Philipp Roesch-Schlanderer will be named and serve as co-founders of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results